News | November 24, 2021
Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
The aim is to support Pharmacovigilance programme across the countries in the region
Early detection of breast cancer increases survival rate by 95 per cent
The 50-bed hospital is positioned to address complexities specific to women and children, going beyond a birthing facility
The new facility will provide an important boost to vaccine capacity in Africa
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
The company proposes to invest up to US $ 50 million, over a period of five years, starting from FY22, to support capability development of talent and technology
Subscribe To Our Newsletter & Stay Updated
